1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Molecular Foundations for Biotechnology (MFB) Program is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI). This program, a joint effort between NSF and NIH, funds research into the structures, functions, and interactions of ribonucleic acid (RNA), as well as the creation of RNA-based technologies.
This includes potential applications in disease prevention and therapies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Research teams with expertise in various fields including chemistry, biology, physics, mathematical modeling, and machine learning. Expected to provide opportunities to partner with industry. Confirm the full requirements in the official notice before applying.
Molecular Foundations for Biotechnology (MFB) Program is funded by National Science Foundation (NSF) & National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleNew NIH awards have fallen 34% in 2026, NSF is running months behind, and a proposed OMB rule would let political appointees terminate grants mid-stream. The funding environment for academic research has structurally changed. Here is a clear-eyed diversification strategy for PIs, research offices, and institutions that cannot wait for the political fight to resolve.
Read articleOMB's proposed rewrite of 2 CFR Part 200 would bar political appointees from deferring to peer reviewers and require senior-appointee sign-off on every discretionary grant. NIH new awards are already down about 34% in 2026. Here is what the merit-review changes actually say, how 'Gold Standard Science' becomes a scoring lever, why R1 universities are being written out of some solicitations, and what principal investigators and research offices should do before October 1.
Read article